The beta‐lactam antibiotic, ceftriaxone, attenuates morphine‐evoked hyperthermia in rats
- 1 August 2007
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 151 (7) , 1095-1102
- https://doi.org/10.1038/sj.bjp.0707309
Abstract
Background and purpose: Beta‐lactam antibiotics are the first practical pharmaceuticals capable of increasing the expression and activity of the glutamate transporter, GLT‐1, in the CNS. However, the functional impact of beta‐lactam antibiotics on specific drugs which produce their pharmacological effects by increasing glutamatergic transmission is unknown. One such drug is morphine, which causes hyperthermia in rats, mediated by an increase in glutamatergic transmission. Since drugs (e.g. antibiotics) that enhance glutamate uptake also decrease glutamatergic transmission, we tested the hypothesis that ceftriaxone, a beta‐lactam antibiotic, would block the glutamate‐dependent portion of morphine‐evoked hyperthermia.Experimental approach: A body temperature assay was used to determine if ceftriaxone decreased morphine‐induced hyperthermia in rats by increasing glutamate uptake.Key results: Body temperatures of rats treated with ceftriaxone (200 mg kg−1, i.p. × 7 days) did not differ from rats receiving saline. Morphine (1, 4, 8 and 15 mg kg−1, s.c.) caused significant hyperthermia. Pre‐treatment with ceftriaxone, as described above, decreased the hyperthermic response to these doses of morphine. The effects of ceftriaxone were prevented by TBOA (0.2 μmol, i.c.v.), an inhibitor of glutamate transport.Conclusions and implications: Ceftriaxone attenuated the hyperthermia caused by morphine, an effect prevented by inhibiting glutamate transport. Thus this effect of ceftriaxone was most likely mediated by increased glutamate uptake. These data revealed a functional interaction between ceftriaxone and morphine and indicated that a beta‐lactam antibiotic decreased the efficacy of morphine in conscious rats.British Journal of Pharmacology(2007)151, 1095–1102; doi:10.1038/sj.bjp.0707309Keywords
This publication has 66 references indexed in Scilit:
- Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) UpregulationStroke, 2007
- The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposureBrain Research, 2006
- Gene transfer of GLT‐1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine‐ and morphine‐induced conditioned place preference in ratsEuropean Journal of Neuroscience, 2005
- β-Lactam antibiotics are multipotent agents to combat neurological diseasesBiochemical and Biophysical Research Communications, 2005
- Brain delta2 opioid receptors mediate SNC-80-evoked hypothermia in ratsBrain Research, 2005
- Merits of a New Drug Trial for ALS?Science, 2005
- Involvement of Glial Glutamate Transporters in Morphine DependenceAnnals of the New York Academy of Sciences, 2004
- Daily Variations in Ceftriaxone Pharmacokinetics in RatsAntimicrobial Agents and Chemotherapy, 2003
- The Effects of NMDA Receptor Antagonists and Nitric Oxide Synthase Inhibitors on Opioid Tolerance and Withdrawal Medication Development Issues for Opiate AddictionNeuropsychopharmacology, 1995
- Diffusion of ceftriaxone into the cerebrospinal fluid of adultsJournal of Antimicrobial Chemotherapy, 1984